1. Home
  2. PSTX vs ETWO Comparison

PSTX vs ETWO Comparison

Compare PSTX & ETWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTX
  • ETWO
  • Stock Information
  • Founded
  • PSTX 2014
  • ETWO 2000
  • Country
  • PSTX United States
  • ETWO United States
  • Employees
  • PSTX N/A
  • ETWO N/A
  • Industry
  • PSTX Biotechnology: Biological Products (No Diagnostic Substances)
  • ETWO EDP Services
  • Sector
  • PSTX Health Care
  • ETWO Technology
  • Exchange
  • PSTX Nasdaq
  • ETWO Nasdaq
  • Market Cap
  • PSTX 909.4M
  • ETWO 936.3M
  • IPO Year
  • PSTX 2020
  • ETWO N/A
  • Fundamental
  • Price
  • PSTX $9.45
  • ETWO $2.64
  • Analyst Decision
  • PSTX Hold
  • ETWO Sell
  • Analyst Count
  • PSTX 3
  • ETWO 3
  • Target Price
  • PSTX $9.00
  • ETWO $3.70
  • AVG Volume (30 Days)
  • PSTX 2.7M
  • ETWO 1.1M
  • Earning Date
  • PSTX 11-07-2024
  • ETWO 01-09-2025
  • Dividend Yield
  • PSTX N/A
  • ETWO N/A
  • EPS Growth
  • PSTX N/A
  • ETWO N/A
  • EPS
  • PSTX N/A
  • ETWO N/A
  • Revenue
  • PSTX $150,858,000.00
  • ETWO $619,301,000.00
  • Revenue This Year
  • PSTX $131.92
  • ETWO N/A
  • Revenue Next Year
  • PSTX N/A
  • ETWO $3.01
  • P/E Ratio
  • PSTX N/A
  • ETWO N/A
  • Revenue Growth
  • PSTX 203.18
  • ETWO N/A
  • 52 Week Low
  • PSTX $1.87
  • ETWO $2.60
  • 52 Week High
  • PSTX $9.58
  • ETWO $5.08
  • Technical
  • Relative Strength Index (RSI)
  • PSTX 86.05
  • ETWO 28.10
  • Support Level
  • PSTX $9.35
  • ETWO $2.89
  • Resistance Level
  • PSTX $9.56
  • ETWO $3.12
  • Average True Range (ATR)
  • PSTX 0.10
  • ETWO 0.12
  • MACD
  • PSTX -0.17
  • ETWO -0.04
  • Stochastic Oscillator
  • PSTX 56.67
  • ETWO 6.25

About PSTX Poseida Therapeutics Inc.

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

About ETWO E2open Parent Holdings Inc.Class A

E2open Parent Holdings Inc is an end-to-end and cloud-based supply chain management SaaS platform. The company's software combines networks, data, and applications to provide a deeply embedded, mission-critical platform that allows customers to optimize the supply chain across channel shaping, business planning, logistics, trade, manufacturing, and supply management. The Group has one reportable segment consisting of cloud-based, end-to-end SCM software. Geographically, the company operates in the Americas, Europe, and Asia Pacific, out of which the majority is from the Americas.

Share on Social Networks: